文献速递肾小球疾病遗传性与小管间质肾病

IgG3κ单克隆膜性肾病伴获得性卵磷脂胆固醇酰基转移酶缺乏症

IgG3κ Monoclonal Membranous Nephropathy Associated With Acquired Lecithin Cholesterol Acyltransferase Deficiency.
PubMed 文献 · Am J Kidney Dis · 2025-09-18

一例老年患者持续极低高密度脂蛋白胆固醇和蛋白尿,血清胆固醇酯显著降低,肾活检示弥漫性肾小球脂质沉积符合卵磷脂胆固醇酰基转移酶(LCAT)缺乏症,但LCAT缺乏相关基因变异检测阴性;肾活检同时显示IgG3κ单克隆膜性肾病,肾小球蛋白组学检测到LCAT和血清淀粉样P(SAP)的肽段谱,提示LCAT可能是伴SAP富集和LCAT缺乏的单克隆膜性肾病的靶抗原;脂质组学显示磷脂酰胆碱和鞘磷脂蓄积、神经酰胺减少;患者接受达雷妥尤单抗治疗,22个月随访时蛋白尿减少而HDL水平仍低。

要点

  • 老年患者持续极低HDL胆固醇和蛋白尿,血清胆固醇酯显著降低,肾活检示弥漫性肾小球脂质沉积符合LCAT缺乏症,但LCAT缺乏相关基因变异检测阴性。
  • 肾活检同时显示IgG3κ单克隆膜性肾病,肾小球蛋白组学检测到LCAT和SAP肽段谱,提示LCAT可能是伴SAP富集和LCAT缺乏的单克隆膜性肾病的靶抗原。
  • 患者接受达雷妥尤单抗治疗,22个月随访时蛋白尿减少而HDL水平仍低。

核心结论

  • 肾小球蛋白组学检测到LCAT和SAP肽段谱,提示LCAT可能是伴SAP富集和LCAT缺乏的单克隆膜性肾病的靶抗原。
  • 患者接受达雷妥尤单抗治疗,22个月随访时蛋白尿减少而HDL水平仍低。

研究设计与样本

  • 本文报告一例老年患者,表现为持续极低HDL和蛋白尿。

主要发现

  • 血清胆固醇酯显著降低,肾活检示弥漫性全球性肾小球脂质沉积,符合LCAT缺乏症经典表现,但LCAT缺乏相关基因变异检测阴性。
  • 肾活检同时显示IgG3κ单克隆膜性肾病。
  • 肾小球蛋白组学检测到LCAT和SAP的肽段谱。
  • 脂质组学显示磷脂酰胆碱和鞘磷脂蓄积、神经酰胺减少。
  • 患者接受达雷妥尤单抗治疗,22个月随访时蛋白尿减少而HDL水平仍低。

临床怎么用

  • 患者接受达雷妥尤单抗治疗,22个月随访时蛋白尿减少而HDL水平仍低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Lecithin cholesterol acyltransferase (LCAT) deficiency, inherited or acquired, is characterized by markedly low plasma high-density lipoprotein (HDL) cholesterol levels and increased unesterified cholesterol. We report a case of an elderly patient with persistently very low HDL and proteinuria. Serum cholesteryl esters were markedly low, and kidney biopsy revealed diffuse global glomerular lipid deposition, classic for LCAT deficiency, whereas genetic testing for variants associated with LCAT deficiency was negative. Kidney biopsy also showed concomitant monoclonal (IgG3κ) membranous nephropathy (MN). Proteomic analysis of glomeruli detected spectra for LCAT and serum amyloid P (SAP), suggesting that LCAT could be a target antigen in monoclonal MN with SAP enrichment and associated LCAT deficiency. Furthermore, lipidomic analysis revealed an accumulation of phosphatidylcholines and sphingomyelin and a decrease in ceramides. The patient was treated with daratumumab, and at 22 months follow-up his proteinuria was decreased while HDL level remained low.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Bu L, Lee JH, Quigley MM, et al. IgG3κ Monoclonal Membranous Nephropathy Associated With Acquired Lecithin Cholesterol Acyltransferase Deficiency. Am J Kidney Dis. 2025. PMID: 40975265. doi:10.1053/j.ajkd.2025.06.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。